I want to get involved. How can I help?

IVI is actively seeking partnerships with stakeholders across the healthcare industry and we welcome your collaboration. You can get more involved if you: Join IVI. IVI's work is only possible with the support of people and organizations like you. Members of IVI are key partners in advancing the science and practice of value assessment. For more [...]

2020-10-23T17:58:37-04:00January 31st, 2019||

What are the benefits of becoming an member of IVI?

IVI is a membership-funded nonprofit, and IVI's ability to achieve its goal depends on the support of forward-thinking organizations and individuals. By joining IVI, you will connect with a growing collaborative community of researchers, patients, payers, employers, and clinicians committed to modern and flexible value assessment. IVI welcomes both individuals and organizational members, and just [...]

2020-10-23T17:50:27-04:00January 31st, 2019||

Who can be a member of IVI?

Any individual or organization interested in advancing the science and improving the practice of healthcare value assessment is welcome to become a member of IVI.

2019-01-31T11:51:40-05:00January 31st, 2019||

What is the Open-Source Value Platform?

Healthcare decision makers are increasingly concerned about making choices based on value – but they need reliable information on value to do so. More importantly, they need information that is specific to them and reflects the context of the actual decision. Fields like cost-effectiveness analysis provide a strong foundation, but the reality is that existing [...]

2019-01-31T11:54:41-05:00January 31st, 2019||

What is available through the Open-Source Value Project?

Multiple OSVP-based resources are available: Disease-specific decision models: IVI has released two disease-specific OSVP decision models for simulating outcomes and assessing relative value of treatment sequences in rheumatoid arthritis (IVI-RA) and EGFR+ non-small cell lung cancer (IVI-NSCLC). The models are open-source, and source code and R packages are free to download and customize. Users can also [...]

2021-07-21T15:50:16-04:00January 31st, 2019||

How do OSVP value assessment models differ from value assessment frameworks such as those from ASCO, ICER, or NCCN?

IVI's OSVP value assessment models have a number of key advantages over these other approaches: Rigorous quantitative analysis: Health benefits, risks and costs are quantified explicitly in OSVP models, making comparison of treatment options more straightforward for decision-makers. Patient-centricity: One of IVI’s primary goals is to improve the ability of value assessment to quantify and incorporate [...]

2019-01-31T11:57:38-05:00January 31st, 2019||

How can I use IVI’s disease-specific models?

There are many ways to use IVI's open-source models to compare the value of treatment sequences in specific diseases (currently rheumatoid arthritis and EGFR+ non-small cell lung cancer). These include: Web-based Value Tools: Two apps, designed for different kinds of user, are available for each model: Basic: Streamlined tool designed for a general user and [...]

2019-01-31T11:58:33-05:00January 31st, 2019||
Go to Top